You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Biogen
since
auto-detected in 8 stories
Quick stats
Top stories today
5 hours ago
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will support its growth, per Piper Sandler.